228 related articles for article (PubMed ID: 14575013)
21. Regional variation in medication following coronary events in Germany.
Müller-Nordhorn J; Kulig M; Binting S; Völler H; Krobot KJ; Willich SN
Int J Cardiol; 2005 Jun; 102(1):47-53. PubMed ID: 15939098
[TBL] [Abstract][Full Text] [Related]
22. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
[TBL] [Abstract][Full Text] [Related]
23. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
[TBL] [Abstract][Full Text] [Related]
24. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
Kawecka-Jaszcz K; Jankowski P; Pajak A
Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
[TBL] [Abstract][Full Text] [Related]
25. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
26. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
[TBL] [Abstract][Full Text] [Related]
28. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
29. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
[TBL] [Abstract][Full Text] [Related]
30. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
[TBL] [Abstract][Full Text] [Related]
31. Absence of sex differences in pharmacotherapy for acute myocardial infarction.
Jelinski SE; Ghali WA; Parsons GA; Maxwell CJ
Can J Cardiol; 2004 Jul; 20(9):899-905. PubMed ID: 15266360
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological and pharmacological profile of congestive heart failure at Turkish academic hospitals.
Ergin A; Eryol NK; Unal S; Deliceo A; Topsakal R; Seyfeli E
Anadolu Kardiyol Derg; 2004 Mar; 4(1):32-8. PubMed ID: 15033616
[TBL] [Abstract][Full Text] [Related]
34. Age, sex, and secondary prevention of ischaemic heart disease in everyday practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Surowiec S; Loster M; Bogacki P; Bryniarska-Mirek E; Grodecki J; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Kardiol Pol; 2013; 71(12):1251-9. PubMed ID: 23799620
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
Román-Sánchez P; Conthe P; García-Alegría J; Forteza-Rey J; Montero M; Montoto C
QJM; 2005 Feb; 98(2):127-38. PubMed ID: 15655095
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic approach in patients with stable angina.
Lettino M; Falcone C; Tavazzi L
Ital Heart J; 2005 Jan; 6(1):1-8. PubMed ID: 15773267
[TBL] [Abstract][Full Text] [Related]
37. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
38. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
[TBL] [Abstract][Full Text] [Related]
39. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic management of heart failure and left ventricular dysfunction following acute myocardial infarction in French intensive care units].
Cambou JP; Vicaut E; Papadopoulos-Degrandsart A; Danchin N
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):36-41. PubMed ID: 17343037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
